All In Biotech

Drug Trial Radar · NCT07559396

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

A Phase 1, Open-Label Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

Last checked: Nov 20, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

May 29, 2026

Primary completion

Jan 4, 2027

Study completion Jan 4, 2027

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Apr 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with severe renal impairment or end stage renal disease.

Conditions

  • Renal Impairment

Interventions

  • INCB123667Drug

    Group 1: Single dose administered orally. Group 2: Two single doses administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PK for plasma INCB123667: CmaxTime frame: Up to approximately 3 months
  2. PK for plasma INCB123667: AUCtTime frame: Up to approximately 3 months
  3. PK for plasma INCB123667: AUC∞Time frame: Up to approximately 3 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Floridian Clinical Research

    Miami Lakes, Florida · Recruiting

  • Orlando Clinical Research Center

    Orlando, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.